 |
Improbable DevelopmentsThe human stories behind the medicines Author: Salem Oaks
Every medicine in your pharmacy has a human story behind it. Real people doing real work and living real lives. We all have romantic ideas about scientists working late into the evening or doctors dropping everything to answer a phone call about a patient. You can almost envision the moment when one of those researchers finally solves an intellectual puzzle and leaps into action. Their eyes go from an empty stare to an alert laser-like focus. They sit a bit taller and start to read frantically. I am sure youve seen those movies too. But is it real? Is that how it really happens? Thats what we intend to explore in Improbable Developments. Each month we will talk to someone who was or is in the trenches of biopharma R&D and let them tell their story. Well be talking about medicines you may know and some that never saw the light of day. Well talk to people involved at the bench in the earliest stages through to those who run the clinical trials and present the data to regulators around the world. We'll even be talking to patients who have joined the effort. The science of drug discovery and development creates a rich landscape for all sorts of stories to unfold. The technical challenges, the urgency to help patients, career aspirations, the fight for resources, and many other factors all work together to produce a complex and enthralling human drama. In our monthly discussions, we will look at this from many different angles. Through our discussions, we hope to give you a real appreciation for the types of people behind the medicines you take and the medical devices you may use. Youll get to know each of them a little bit and start to understand what they have in common and how different and unique they really are. We at Salem Oaks love to bring you these stories of people who are involved in the science, process, and profession of finding and developing new medicines. In our Emerging Researchers Series, we are even talking to people just entering the field and we hope Language: en Genres: Health & Fitness, Life Sciences, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Amy Grover: Building Bridges Between Patients and Biopharma
Episode 19
Tuesday, 17 August, 2021
“Pharmaceutical companies sometimes have a bad rap of being, you know, big, bad pharmacy. But I learned that the patient or the people I am working with right now are just as passionate and just as dedicated to the patient community as I am.” Amy Grover, Director of Patient Advocacy at Catalyst PharmaceuticalsAmy Grover is a familiar face to the rare disease community. She spent 10 years at Global Genes before joining Catalyst Pharmaceuticals. At Global Genes she learned about rare diseases and the challenges they create for people. In her job now, she is working to bridge the gap between biopharma and the patients and families affected diseases like Lambert-Eaton Myasthenic Syndrome (LEMS). Sounds like a familiar mission.Amy moved from the patient side to industry much like I moved from industry to the patient world. We both were surprised by a few things that we saw as we passed through the looking glass between the two. We both recognize that one of the first steps to bridging this gap is mutual respect. If we work on this, the benefits of partnering will flow. I really enjoyed sharing insights looking at the problem from both directions. www.catlystpharma.com
